Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET

Company Participants

Rob Shawah - Chief Financial Officer

David Luci - President and Chief Executive Officer

Conference Call Participants

Chad Yahn - Maxim Group

Joanne Lee - Maxim Group

Operator

Greetings and welcome to the Acurx Pharmaceuticals, Inc. First Quarter 2022 Results and Business Update. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, the conference is being recorded.

I would now like to turn the conference over to your host, Rob Shawah, Chief Financial Officer. Please go ahead.

Rob Shawah

Thank you. Good morning, and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the first quarter of 2022. This press release is available on our website at acurxpharmaceuticals.com.

Joining me today is Dave Luci, President and Chief Executive Officer of Acurx, who will give a corporate update and outlook for the remainder of 2022. After that, I'll provide some highlights to the financials from the quarter-ended March 31, and then turn the call back over to Dave for his closing remarks.

As a reminder, during todays' call, we’ll be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions, estimates and projections about future events that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.

Investors should consider these risks and other information described in our filings made with the securities and exchange commission, including our quarterly report on Form 10-Q, which we filed yesterday, Tuesday, May 10.

You are cautioned not to place undue reliance on these forward-looking statements and Acurx disclaims any obligation to update such statements at any time in the future. This conference call contains time-sensitive information that’s accurate only as of the date of this live broadcast today, May 11. Acurx undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date and time of this conference call.

I'll now turn the call over to Dave Luci. Dave?

David Luci

Thank you, Rob. Good morning, everyone and thanks for joining us on this conference call to review our financial results. During today's call we’ll review our financial results for the first quarter ended March 31 and also cover some key corporate highlights and then we'd be pleased to take any questions.